Chris Godwin

Chris Godwin has twice been a top-five fantasy receiver. Last year a fractured leg held him to nine games and seven points a game. Now Mike Evans is gone, the targets are open, and Godwin's the fortieth receiver off the board. Healthy, he's a steal; that's the whole question. The Muffed 2026 preview.

The 2025 season was a lost one: thirty-three catches for three hundred sixty yards and two touchdowns in nine games, seven-four a game, WR49 per game — capped by a fibula injury suffered early, on top of the ankle that ended his 2024. The signature, a seven-catch, a hundred eight-yard, one-score day against Miami in Week 17, was a glimpse of the player when right. But it was nine games of a diminished version.

The arc is the reason for interest: a decade of high-end production, including a sixteen-seven-a-game peak and another sixteen-one as recently as 2024 — before the injuries. The talent and the role, when healthy, are WR1-caliber; he's a career-year-nine receiver whose down year was a broken leg, not decline.

What the data says: the touchdown rate is low and the sample is tiny, so 2025 tells us little except that he was hurt. The relevant facts are the proven volume and the fact that he's a slot technician whose game ages relatively well. The risk is the body — back-to-back significant lower-leg injuries are a real flag at his age.

The situation, per the reports, swings it toward opportunity — and this offseason gave the health column its first real evidence: for the first time in three years, Godwin spent the spring training for football instead of recovering from surgery. Todd Bowles at OTAs: "He's great. He's healthy." The GM's April read: "He was looking like he was back to himself." Mike Evans is in San Francisco, vacating a huge target share, and a healthy Godwin in the slot — with Emeka Egbuka established and Jalen McMillan alongside — has a clear path back to volume. The scar tissue is still the story: two fibula injuries in two years, the second in a different spot than the first.

The price: pick ninety-three, the fortieth receiver. Verdict: WATCHLIST — the proven WR1 ceiling and the vacated Evans targets argue he's underpriced; the back-to-back leg injuries and his age argue you can't bank it. The counter for him: when healthy he's a top-tier slot producer, the opportunity just expanded, and for once the spring reporting is unambiguous. Against: "when healthy" is still carrying a lot after two lower-leg injuries in two years. The upside is real; so is the risk.

September watch: his health and snap count first — the leg is the question; then the target share with Evans gone and Egbuka established. He's one of your guys? This show covers your whole roster — every player, every week, all season.